Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Endothelial progenitor cells are cellular hubs essential for neoangiogenesis of certain aggressive adenocarcinomas and metastatic transition but not adenomas.

Literature DB >> 18715995

Endothelial progenitor cells are cellular hubs essential for neoangiogenesis of certain aggressive adenocarcinomas and metastatic transition but not adenomas.

Robert S Kerbel, Robert Benezra, David C Lyden, Koichi Hattori, Beate Heissig, Daniel J Nolan, Vivek Mittal, Yuval Shaked, Sergio Dias, Francesco Bertolini, Shahin Rafii.

Abstract

Entities: Disease

Mesh：

Year: 2008 PMID： 18715995 PMCID： PMC2527966 DOI： 10.1073/pnas.0804876105

Source DB: PubMed Journal: Proc Natl Acad Sci U S A ISSN： 0027-8424 Impact factor: 11.205

× No keyword cloud information.

7 in total

1. Chemokines direct endothelial progenitors into tumor neovessels.

Authors: Herbert Spring; Thomas Schüler; Bernd Arnold; Günter J Hämmerling; Ruth Ganss
Journal: Proc Natl Acad Sci U S A Date: 2005-12-02 Impact factor: 11.205

2. Contribution of bone marrow-derived endothelial cells to human tumor vasculature.

Authors: Brock A Peters; Luis A Diaz; Kornelia Polyak; Leslie Meszler; Kathy Romans; Eva C Guinan; Joseph H Antin; David Myerson; Stanley R Hamilton; Bert Vogelstein; Kenneth W Kinzler; Christoph Lengauer
Journal: Nat Med Date: 2005-02-20 Impact factor: 53.440

3. Extracardiac progenitor cells repopulate most major cell types in the transplanted human heart.

Authors: Elina Minami; Michael A Laflamme; Jeffrey E Saffitz; Charles E Murry
Journal: Circulation Date: 2005-11-08 Impact factor: 29.690

Review 4. The multifaceted circulating endothelial cell in cancer: towards marker and target identification.

Authors: Francesco Bertolini; Yuval Shaked; Patrizia Mancuso; Robert S Kerbel
Journal: Nat Rev Cancer Date: 2006-10-05 Impact factor: 60.716

5. Bone marrow-derived circulating endothelial precursors do not contribute to vascular endothelium and are not needed for tumor growth.

Authors: Susanna Purhonen; Jarmo Palm; Derrick Rossi; Nina Kaskenpää; Iiro Rajantie; Seppo Ylä-Herttuala; Kari Alitalo; Irving L Weissman; Petri Salven
Journal: Proc Natl Acad Sci U S A Date: 2008-04-28 Impact factor: 11.205

6. VEGFR-3 and CD133 identify a population of CD34+ lymphatic/vascular endothelial precursor cells.

Authors: Petri Salven; Satu Mustjoki; Riitta Alitalo; Kari Alitalo; Shahin Rafii
Journal: Blood Date: 2002-08-15 Impact factor: 22.113

7. Endothelial progenitor cells control the angiogenic switch in mouse lung metastasis.

Authors: Dingcheng Gao; Daniel J Nolan; Albert S Mellick; Kathryn Bambino; Kevin McDonnell; Vivek Mittal
Journal: Science Date: 2008-01-11 Impact factor: 47.728

7 in total

23 in total

1. Bone marrow is a reservoir for proangiogenic myelomonocytic cells but not endothelial cells in spontaneous tumors.

Authors: Andrew C Dudley; Taturo Udagawa; Juan M Melero-Martin; Shou-Ching Shih; Adam Curatolo; Marsha A Moses; Michael Klagsbrun
Journal: Blood Date: 2010-05-07 Impact factor: 22.113

Review 2. Targeting stroma to treat cancers.

Authors: Boris Engels; Donald A Rowley; Hans Schreiber
Journal: Semin Cancer Biol Date: 2011-12-24 Impact factor: 15.707

Review 3. Endothelial progenitor cells: current issues on characterization and challenging clinical applications.

Authors: Thomas Resch; Andreas Pircher; Christian M Kähler; Johann Pratschke; Wolfgang Hilbe
Journal: Stem Cell Rev Rep Date: 2012-09 Impact factor: 5.739

Review 4. Stem cells and the vasculature.

Authors: Victoria L Bautch
Journal: Nat Med Date: 2011-11-07 Impact factor: 53.440

Endothelial progenitor cells are cellular hubs essential for neoangiogenesis of certain aggressive adenocarcinomas and metastatic transition but not adenomas.

1. Chemokines direct endothelial progenitors into tumor neovessels.

2. Contribution of bone marrow-derived endothelial cells to human tumor vasculature.

3. Extracardiac progenitor cells repopulate most major cell types in the transplanted human heart.

Review 4. The multifaceted circulating endothelial cell in cancer: towards marker and target identification.

5. Bone marrow-derived circulating endothelial precursors do not contribute to vascular endothelium and are not needed for tumor growth.

6. VEGFR-3 and CD133 identify a population of CD34+ lymphatic/vascular endothelial precursor cells.

7. Endothelial progenitor cells control the angiogenic switch in mouse lung metastasis.

1. Bone marrow is a reservoir for proangiogenic myelomonocytic cells but not endothelial cells in spontaneous tumors.

Review 2. Targeting stroma to treat cancers.

Review 3. Endothelial progenitor cells: current issues on characterization and challenging clinical applications.

Review 4. Stem cells and the vasculature.

5. Angiogenic monocytes: another colorful blow to endothelial progenitors.

Review 6. Microenvironmental regulation of tumor progression and metastasis.

Review 7. The pro-metastatic role of bone marrow-derived cells: a focus on MSCs and regulatory T cells.

8. Hsp90 as a gatekeeper of tumor angiogenesis: clinical promise and potential pitfalls.

9. Progress on antiangiogenic therapy for patients with malignant glioma.

Review 10. Microenvironmental regulation of metastasis.